Pivotal Therapeutics Inc. (OCTPK:PVTT.F) announced a non-brokered private placement of 22,000,000 common shares at a price of CAD 0.07 per common share for gross proceeds of CAD 1,540,000 on June 29, 2015. The company will pay finder's fee in the transaction. The completion of the transaction is dependent upon receiving the prior written consent of company's existing convertible promissory note holders, such consent not to be unreasonably withheld or delayed.

One significant note holder has already given their consent.